🇺🇸 FDA
Pipeline program

99mTc-pyrophosphate Scintigraphy

2020P002061

Unknown other active

Quick answer

99mTc-pyrophosphate Scintigraphy for Transthyretin Amyloidosis is a Unknown program (other) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ALNYLAM PHARMACEUTICALS, INC.
Indication
Transthyretin Amyloidosis
Phase
Unknown
Modality
other
Status
active

Clinical trials